miércoles, 1 de agosto de 2018

New Discovery: LRRK2 Therapies Could Benefit Wider Population | FoxFlash July 2018

Fox Flash - Donate
Wider Population May Benefit from LRRK2 Therapies in Development
Discover More
New findings from a Foundation-funded study suggest that the LRRK2 protein may have a role in Parkinson's disease among people who don't carry the LRRK2mutation. This means that LRRK2-targeted treatments currently in development also could be useful for people without the mutation.
Discover More >


Urinary Problems in Parkinson's Disease
Hear expert discussion and ask your questions in our Third Thursdays Webinar series. 
August 16, 2018 at 12 p.m. ET

No hay comentarios:

Publicar un comentario